Key facts
- Inlisol’s last known valuation is $1.3M (Dec 2023).
- It has raised $110K; the latest was Early Stage VC in Jan 2025.
- Notable investors include Innovestor, Vesa Salin.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Inlisol
- ·The full record, as it builds
Funding rounds
No funding rounds for Inlisol are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Inlisol
Developer of an AI-based technology designed for monitoring well-being. The company's platform utilizes intelligent activity sensors to discreetly track resident movements and behaviors, coupled with advanced software that leverages AI monitoring capabilities to deliver real-time data for personalized care and continuous insight into residents' activity, enabling nursing homes, home care services, and family members to improve care efficiency.
- Sector
- Healthcare
- HQ
- Uusikaupunki, Finland
- Founded
- 2021
- Employees
- 7
- Website
- inlisol.com/
- Ownership
- Privately Held (backing)
Inlisol doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Inlisol shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Inlisol in its N-PORT filings yet. We sweep new filings monthly.